Daniel E. Geffken Windtree Therapeutics Inc (WINT) insider trading activity

WINT Quotes by TradingView

Daniel E. Geffken is Director of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 2,175 shares of WINT, which is worth approximately $1,522. The most recent transaction as insider was on Aug 23, 2023, when has been sold 2,033 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.18K
0% 3M change
0% 12M change
Total Value Held $1,522

Daniel E. Geffken Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
BUY
Grant, award, or other acquisition
-
2,033 Added 48.31%
2,175 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
5,000 Added 41.43%
7,069 Common Stock

Also insider at

EFTR
eFFECTOR Therapeutics, Inc. Healthcare
Chief Financial Officer
ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
INTERIM CFO
PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
Chief Financial Officer
GRAY
GRAYBUG VISION, INC. Healthcare
Interim CFO
PMN
ProMIS Neurosciences Inc.
Chief Financial Officer
DEG

Daniel E. Geffken

Director
Philadelphia, PA

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on WINT